Table 2 WHO classification of 100 patients with AML
WHO classification | N (%) |
|---|---|
APL with PML-RARα | 40 (40.0) |
AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 | 10 (10.0) |
AML with inv.(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | 7 (7.0) |
AML with t(9;11)(p21.3;q23.3); MLLT3-KMT2A | 12 (12.0) |
AML with minimal differentiation | 6 (6.0) |
Acute myelomonocytic leukaemia | 25 (25.0) |